British Journal of Clinical Pharmacology

Cover image for Vol. 83 Issue 2

Early View (Online Version of Record published before inclusion in an issue)

Edited By: A.F. Cohen (Editor-in-Chief), A. de Boer (European Editor), A. Ferro (Reviews Editor), A. Gilchrist (Online Editor), G. Isbister (Australasian Editor), S. Ross (Education Editor) and A. Webb (European Editor)

Impact Factor: 3.83

ISI Journal Citation Reports © Ranking: 2015: 49/255 (Pharmacology & Pharmacy)

Online ISSN: 1365-2125

Associated Title(s): British Journal of Pharmacology, Pharmacology Research & Perspectives

VIEW

  1. 1 - 66
  1. DRUG SAFETY

    1. You have free access to this content
      Adverse reactions to dietary supplements containing red yeast rice: assessment of cases from the Italian surveillance system

      Gabriela Mazzanti, Paola Angela Moro, Emanuel Raschi, Roberto Da Cas and Francesca Menniti-Ippolito

      Version of Record online: 19 JAN 2017 | DOI: 10.1111/bcp.13171

  2. REVIEWS

  3. CLINICAL TRIALS

    1. You have full text access to this OnlineOpen article
      Cardiac effects of amiselimod compared with fingolimod and placebo: results of a randomised, parallel-group, phase I study in healthy subjects

      Tomohiko Harada, Darren Wilbraham, Guillemette de La Borderie, Shinsuke Inoue, Jim Bush and A. John Camm

      Version of Record online: 19 JAN 2017 | DOI: 10.1111/bcp.13203

      • image
      • image
      • image
      • image
      • image
  4. PAEDIATRIC CLINICAL PHARMACOLOGY

    1. Prediction of serum theophylline concentrations and cytochrome P450 1A2 activity by analyzing urinary metabolites in preterm infants

      Jin A Sohn, Han-Suk Kim, Jaeseong Oh, Joo-Youn Cho, Kyung-Sang Yu, Juyoung Lee, Seung Han Shin, Jin A Lee, Chang Won Choi, Ee-Kyung Kim, Beyong Il Kim and Eun Ae Park

      Version of Record online: 18 JAN 2017 | DOI: 10.1111/bcp.13211

      • image
      • image
  5. CLINICAL TRIALS

    1. Extended-release niacin increases anti-apolipoprotein A-I antibodies that block the antioxidant effect of high-density lipoprotein–cholesterol: the EXPLORE clinical trial

      Joana R. Batuca, Marta C. Amaral, Catarina Favas, Filipe S. Paula, Paul R. J. Ames, Ana L. Papoila and José Delgado Alves

      Version of Record online: 18 JAN 2017 | DOI: 10.1111/bcp.13198

      • image
      • image
  6. SYSTEMATIC REVIEWS

    1. A systematic review of the outcomes reported in trials of medication review in older patients: the need for a core outcome set

      Jean-Baptiste Beuscart, Lisa G. Pont, Stefanie Thevelin, Benoit Boland, Olivia Dalleur, Anne W.S. Rutjes, Johanna I. Westbrook and Anne Spinewine

      Version of Record online: 18 JAN 2017 | DOI: 10.1111/bcp.13197

      • image
      • image
  7. PHARMACOEPIDEMIOLOGY

    1. SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn

      Anick Bérard, Odile Sheehy, Jin-Ping Zhao, Évelyne Vinet, Sasha Bernatsky and Michal Abrahamowicz

      Version of Record online: 18 JAN 2017 | DOI: 10.1111/bcp.13194

      • image
  8. LETTER TO THE EDITOR

    1. Pharmacokinetics of first-line antitubercular drugs in plasma and PBMCs

      Ilaria Motta, Andrea Calcagno, Lorena Baietto, Paolo Bigliano, Cecilia Costa, Katia Baruffi, Giovanna Fatiguso, Antonio D'Avolio, Giovanni Di Perri and Stefano Bonora

      Version of Record online: 18 JAN 2017 | DOI: 10.1111/bcp.13196

  9. REVIEWS

    1. Is there potential for therapeutic drug monitoring of biologic agents in rheumatoid arthritis?

      Carla Bastida, Virginia Ruíz, Mariona Pascal, Jordi Yagüe, Raimon Sanmartí and Dolors Soy

      Version of Record online: 18 JAN 2017 | DOI: 10.1111/bcp.13192

  10. DRUG SAFETY

  11. DRUG INTERACTIONS

    1. Effect of ketoconazole, a strong CYP3A inhibitor, on the pharmacokinetics of venetoclax, a BCL-2 inhibitor, in patients with non-Hodgkin lymphoma

      Suresh K. Agarwal, Ahmed Hamed Salem, Alexey V. Danilov, Beibei Hu, Soham Puvvada, Martin Gutierrez, David Chien, Lionel D. Lewis and Shekman L. Wong

      Version of Record online: 18 JAN 2017 | DOI: 10.1111/bcp.13175

      • image
      • image
      • image
      • image
  12. PHARMACOKINETICS

    1. Population pharmacokinetics of rifampicin in adult patients with osteoarticular infections: interaction with fusidic acid

      Amélie Marsot, Amelie Ménard, Julien Dupouey, Cedric Muziotti, Romain Guilhaumou and Olivier Blin

      Version of Record online: 16 JAN 2017 | DOI: 10.1111/bcp.13178

      • image
      • image
      • image
      • image
      • image
      • image
  13. CLINICAL TRIALS

    1. Venlafaxine and oxycodone have different effects on spinal and supraspinal activity in man: a somatosensory evoked potential study

      Dina Lelic, Massimiliano Valeriani, Iben W. D. Fischer, Albert Dahan and Asbjørn M. Drewes

      Version of Record online: 16 JAN 2017 | DOI: 10.1111/bcp.13177

      • image
      • image
      • image
      • image
  14. SYSTEMATIC REVIEWS

  15. PAEDIATRIC CLINICAL PHARMACOLOGY

    1. Aprepitant in pediatric patients using moderate and highly emetogenic protocols: a systematic review and meta-analyses of randomized controlled trials

      Lucas Miyake Okumura, Fernanda D'Athayde Rodrigues, Maria Angelica Pires Ferreira and Leila Beltrami Moreira

      Version of Record online: 12 JAN 2017 | DOI: 10.1111/bcp.13193

      • image
      • image
      • image
  16. DRUG SAFETY

    1. The effect of prescriber education on medication-related patient harm in the hospital: a systematic review

      Jacqueline M. Bos, Patricia M.L.A. van den Bemt, Peter A.G.M. de Smet and Cornelis Kramers

      Version of Record online: 12 JAN 2017 | DOI: 10.1111/bcp.13200

      • image
  17. PHARMACOEPIDEMIOLOGY

    1. Characterization of adverse drug reactions causing admission to an intensive care unit

      Camilo Rojas-Velandia, Jair Ruiz-Garzón, Juan-Carlos Moscoso-Alcina, Álvaro Vallejos-Narvaéz, Jenny Castro-Canoa, Yuri Bustos-Martínez, Max Flórez-Cutiva, Mabel Contreras-Muñoz, Jully-Carolina Gómez-Gil and Carlos-Alberto Calderón-Ospina

      Version of Record online: 10 JAN 2017 | DOI: 10.1111/bcp.13199

  18. CLINICAL TRIALS

    1. You have full text access to this OnlineOpen article
      First-in-human randomized study of bimekizumab, a humanized monoclonal antibody and selective dual inhibitor of IL-17A and IL-17F, in mild psoriasis

      Sophie Glatt, Eric Helmer, Birgit Haier, Foteini Strimenopoulou, Graham Price, Pavan Vajjah, Olivier A. Harari, John Lambert and Stevan Shaw

      Version of Record online: 10 JAN 2017 | DOI: 10.1111/bcp.13185

      • image
      • image
      • image
      • image
      • image
    2. The use of a battery of pain models to detect analgesic properties of compounds: a two-part four-way crossover study

      Pieter Okkerse, Guido van Amerongen, Marieke L. de Kam, Jasper Stevens, Richard P. Butt, Rachel Gurrell, Albert Dahan, Joop M. van Gerven, Justin L. Hay and Geert Jan Groeneveld

      Version of Record online: 9 JAN 2017 | DOI: 10.1111/bcp.13183

      • image
      • image
      • image
      • image
      • image
  19. LETTER TO THE EDITOR

    1. Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance

      Elisabet Størset, Kristine Hole, Karsten Midtvedt, Stein Bergan, Espen Molden and Anders Åsberg

      Version of Record online: 22 DEC 2016 | DOI: 10.1111/bcp.13188

      • image
  20. HUMAN TOXICOLOGY

    1. Central nervous system toxicity of mefenamic acid overdose compared with other NSAIDs: an analysis of cases reported to the United Kingdom National Poisons Information Service

      Ashraf Kamour, Siobhan Crichton, Gill Cooper, David J. Lupton, Michael Eddleston, J. Allister Vale, John P. Thompson and Simon H. L. Thomas

      Version of Record online: 22 DEC 2016 | DOI: 10.1111/bcp.13169

      • image
  21. DRUG INTERACTIONS

    1. In vitro and physiologically-based pharmacokinetic based assessment of drug–drug interaction potential of canagliflozin

      Rao N. V. S. Mamidi, Shannon Dallas, Carlo Sensenhauser, Heng Keang Lim, Ellen Scheers, Peter Verboven, Filip Cuyckens, Laurent Leclercq, David C. Evans, Michael F. Kelley, Mark D. Johnson and Jan Snoeys

      Version of Record online: 20 DEC 2016 | DOI: 10.1111/bcp.13186

      • image
      • image
      • image
      • image
      • image
      • image
  22. PHARMACOKINETICS

    1. Tolerability, pharmacokinetics and antiviral activity of rHSA/IFNα2a for the treatment of chronic hepatitis B infection

      Yanhua Ding, Jinfeng Lou, Hong Chen, Xiaojiao Li, Min Wu, Cuiyun Li, Jingrui Liu, Chengjiao Liu, Qingmei Li, Hong Zhang and Junqi Niu

      Version of Record online: 20 DEC 2016 | DOI: 10.1111/bcp.13184

      • image
      • image
      • image
      • image
      • image
      • image
  23. PAEDIATRIC CLINICAL PHARMACOLOGY

    1. Population pharmacokinetics of temsirolimus and sirolimus in children with recurrent solid tumours: a report from the Children's Oncology Group

      Tomoyuki Mizuno, Tsuyoshi Fukuda, Uwe Christians, John P. Perentesis, Maryam Fouladi and Alexander A. Vinks

      Version of Record online: 20 DEC 2016 | DOI: 10.1111/bcp.13181

      • image
      • image
      • image
      • image
      • image
  24. CLINICAL TRIALS

    1. Pharmacokinetics and pharmacodynamics of a new highly concentrated intranasal midazolam formulation for conscious sedation

      Lenneke Schrier, Rob Zuiker, Frans W. H. M. Merkus, Erica S. Klaassen, Zheng Guan, Bert Tuk, Joop M. A. van Gerven, Ronald van der Geest and Geert Jan Groeneveld

      Version of Record online: 20 DEC 2016 | DOI: 10.1111/bcp.13163

      • image
      • image
      • image
      • image
      • image
    2. Pharmacokinetics and pharmacodynamics of intrathecally administered Xen2174, a synthetic conopeptide with norepinephrine reuptake inhibitor and analgesic properties

      Pieter Okkerse, Justin L. Hay, Elske Sitsen, Albert Dahan, Erica Klaassen, William Houghton and Geert Jan Groeneveld

      Version of Record online: 16 DEC 2016 | DOI: 10.1111/bcp.13176

      • image
      • image
      • image
      • image
    3. GP2015, a proposed etanercept biosimilar: Pharmacokinetic similarity to its reference product and comparison of its autoinjector device with prefilled syringes

      Oliver von Richter, Andrej Skerjanec, Miguel Afonso, Sabine Sanguino Heinrich, Johann Poetzl, Heike Woehling, Maria Velinova, Annelize Koch, Dmitrij Kollins, Lars Macke and Guido Wuerth

      Version of Record online: 16 DEC 2016 | DOI: 10.1111/bcp.13170

      • image
      • image
      • image
      • image
  25. PAEDIATRIC CLINICAL PHARMACOLOGY

    1. Tacrolimus dose requirements in paediatric renal allograft recipients are characterized by a biphasic course determined by age and bone maturation

      Noël Knops, Jean Herman, Maria van Dyck, Yasaman Ramazani, Edward Debbaut, Rita van Damme-Lombaerts, Elena Levtchenko, Lambertus P. van den Heuvel, Steffen Fieuws and Dirk Kuypers

      Version of Record online: 13 DEC 2016 | DOI: 10.1111/bcp.13174

      • image
      • image
      • image
      • image
  26. PHARMACOKINETICS

    1. Assessment of pharmacokinetic interaction between rilotumumab and epirubicin, cisplatin and capecitabine (ECX) in a Phase 3 study in gastric cancer

      Yilong Zhang, Mita Kuchimanchi, Min Zhu, Sameer Doshi, Tien Hoang and Sreeneeranj Kasichayanula

      Version of Record online: 13 DEC 2016 | DOI: 10.1111/bcp.13179

      • image
      • image
      • image
      • image
      • image
    2. Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activation

      Christopher Vinnard, Shruthi Ravimohan, Neo Tamuhla, Vijay Ivaturi, Jotam Pasipanodya, Shashikant Srivastava, Chawangwa Modongo, Nicola M. Zetola, Drew Weissman, Tawanda Gumbo and Gregory P. Bisson

      Version of Record online: 9 DEC 2016 | DOI: 10.1111/bcp.13172

      • image
      • image
      • image
  27. PHARMACOEPIDEMIOLOGY

    1. The use of incretins and fractures – a meta-analysis on population-based real life data

      Johanna H. M. Driessen, Frank de Vries, Hein van Onzenoort, Nicholas C. Harvey, Cees Neef, Joop P. W. van den Bergh, Peter Vestergaard and Ronald M. A. Henry

      Version of Record online: 7 DEC 2016 | DOI: 10.1111/bcp.13167

  28. CLINICAL TRIALS

    1. You have full text access to this OnlineOpen article
      Randomized, controlled, multicentre clinical trial of the antipyretic effect of intravenous paracetamol in patients admitted to hospital with infection

      Thomas Tsaganos, Ioulia K. Tseti, Nikolaos Tziolos, Georgios-Stefanos Soumelas, Marina Koupetori, Athina Pyrpasopoulou, Karolina Akinosoglou, Charalambos Gogos, Nikolaos Tsokos, Asterios Karagiannis, Styliani Sympardi and Evangelos J. Giamarellos-Bourboulis

      Version of Record online: 7 DEC 2016 | DOI: 10.1111/bcp.13173

      • image
      • image
      • image
      • image
  29. DRUG SAFETY

    1. Lessons learned on the design and the conduct of Post-Authorization Safety Studies: review of 3 years of PRAC oversight

      Pierre Engel, Mariana Ferreira Almas, Marieke Louise De Bruin, Kathryn Starzyk, Stella Blackburn and Nancy Ann Dreyer

      Version of Record online: 7 DEC 2016 | DOI: 10.1111/bcp.13165

      • image
      • image
  30. PHARMACOKINETICS

    1. Maturation of oxycodone pharmacokinetics in neonates and infants: Oxycodone and its metabolites in plasma and urine

      Merja Kokki, Marja Heikkinen, Pyry Välitalo, Heidi Hautajärvi, Juho Hokkanen, Hanna Pitkänen, Ulla Sankilampi, Veli-Pekka Ranta and Hannu Kokki

      Version of Record online: 5 DEC 2016 | DOI: 10.1111/bcp.13164

      • image
      • image
      • image
      • image
  31. DRUGS IN PREGNANCY AND LACTATION

    1. Sertraline use in the first trimester and risk of congenital anomalies: a systemic review and meta-analysis of cohort studies

      Zi-Qi Shen, Shan-Yan Gao, Shawn Xiang Li, Tie-Ning Zhang, Cai-Xia Liu, Hai-Chen Lv, Yuan Zhang, Ting-Ting Gong, Xin Xu, Chao Ji, Qi-Jun Wu and Da Li

      Version of Record online: 4 DEC 2016 | DOI: 10.1111/bcp.13161

      • image
      • image
      • image
  32. PHARMACOKINETICS

    1. You have full text access to this OnlineOpen article
      Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful?

      Eva Germovsek, Charlotte I. S. Barker, Mike Sharland and Joseph F. Standing

      Version of Record online: 2 DEC 2016 | DOI: 10.1111/bcp.13160

      • image
      • image
      • image
  33. PHARMACOKINETIC DYNAMIC RELATIONSHIPS

    1. Effect of opicapone multiple-dose regimens on levodopa pharmacokinetics

      José-Francisco Rocha, Éric Sicard, Nicolas Fauchoux, Amílcar Falcão, Ana Santos, Ana I. Loureiro, Roberto Pinto, Maria João Bonifácio, Teresa Nunes, Luís Almeida and Patrício Soares-da-Silva

      Version of Record online: 2 DEC 2016 | DOI: 10.1111/bcp.13156

      • image
      • image
      • image
  34. CLINICAL TRIALS

    1. A Phase I study to determine the pharmacokinetic profile, safety and tolerability of sildenafil (Revatio®) in cardiac surgery: the REVAKI-1 study

      Arne Ring, Tom Morris, Marcin Wozniak, Nikol Sullo, William Dott, Veerle Verheyden, Tracy Kumar, Nigel Brunskill, Rakesh Vaja and Gavin J. Murphy

      Version of Record online: 1 DEC 2016 | DOI: 10.1111/bcp.13162

      • image
      • image
      • image
      • image
  35. PHARMACOKINETIC DYNAMIC RELATIONSHIPS

    1. The pharmacokinetics and pharmacodynamics of mycophenolate mofetil in younger and elderly renal transplant recipients

      Jiang-Tao Tang, Brenda C. de Winter, Dennis A. Hesselink, Ferdi Sombogaard, Lan-Lan Wang and Teun van Gelder

      Version of Record online: 30 NOV 2016 | DOI: 10.1111/bcp.13154

      • image
      • image
      • image
      • image
  36. PHARMACOEPIDEMIOLOGY

    1. Effects of policy interventions on the introduction of novel oral anticoagulants in Stockholm: an interrupted time series analysis

      Joris Komen, Tomas Forslund, Paul Hjemdahl, Morten Andersen and Björn Wettermark

      Version of Record online: 30 NOV 2016 | DOI: 10.1111/bcp.13150

      • image
      • image
      • image
      • image
  37. DRUG SAFETY

    1. Factors affecting patient reporting of adverse drug reactions: a systematic review

      Rania Al Dweik, Dawn Stacey, Dafna Kohen and Sanni Yaya

      Version of Record online: 25 NOV 2016 | DOI: 10.1111/bcp.13159

      • image
      • image
  38. PHARMACOKINETIC DYNAMIC RELATIONSHIPS

    1. Theory-based pharmacokinetics and pharmacodynamics of S- and R-warfarin and effects on international normalized ratio: influence of body size, composition and genotype in cardiac surgery patients

      Ling Xue, Nick Holford, Xiao-liang Ding, Zhen-ya Shen, Chen-rong Huang, Hua Zhang, Jing-jing Zhang, Zhe-ning Guo, Cheng Xie, Ling Zhou, Zhi-yao Chen, Lin-sheng Liu and Li-yan Miao

      Version of Record online: 25 NOV 2016 | DOI: 10.1111/bcp.13157

      • image
      • image
      • image
  39. DRUG INTERACTIONS

    1. Adverse events associated with interactions with dietary and herbal supplements among inpatients

      Ilana Levy, Samuel Attias, Eran Ben-Arye, Lee Goldstein and Elad Schiff

      Version of Record online: 25 NOV 2016 | DOI: 10.1111/bcp.13158

      • image
  40. REVIEWS

    1. Impact of concomitant medications on obstructive sleep apnoea

      Ingrid Jullian-Desayes, Bruno Revol, Elisa Chareyre, Philippe Camus, Céline Villier, Jean-Christian Borel, Jean-Louis Pepin and Marie Joyeux-Faure

      Version of Record online: 24 NOV 2016 | DOI: 10.1111/bcp.13153

  41. CLINICAL TRIALS

    1. Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis

      Malcolm Boyce, Andrew R. Moore, Liv Sagatun, Bryony N. Parsons, Andrea Varro, Fiona Campbell, Reidar Fossmark, Helge L. Waldum and D. Mark Pritchard

      Version of Record online: 21 NOV 2016 | DOI: 10.1111/bcp.13146

      • image
      • image
      • image
      • image
  42. CASE REPORTS

    1. Pharmacokinetic interaction between taxanes and amiodarone leading to severe toxicity

      Felix Hammann, Verena Gotta, Katrin Conen, Michael Medinger, Philipp Cesana, Christoph Rochlitz and Anne B. Taegtmeyer

      Version of Record online: 20 NOV 2016 | DOI: 10.1111/bcp.13155

      • image
  43. PHARMACODYNAMICS

    1. The variability in beta-cell function in placebo-treated subjects with type 2 diabetes: application of the weight-HbA1c-insulin-glucose (WHIG) model

      Janna K. Duong, Willem de Winter, Steve Choy, Nele Plock, Himanshu Naik, Walter Krauwinkel, Sandra A.G. Visser, Katia M. Verhamme, Miriam C. Sturkenboom, B.H. Stricker and Meindert Danhof

      Version of Record online: 17 NOV 2016 | DOI: 10.1111/bcp.13144

      • image
      • image
      • image
  44. METHODS IN CLINICAL PHARMACOLOGY

    1. Development of an in vivo target-engagement biomarker for TRPA1 antagonists in humans

      Linde Buntinx, Lin Chang, Aasim Amin, Bart Morlion and Jan de Hoon

      Version of Record online: 17 NOV 2016 | DOI: 10.1111/bcp.13143

      • image
      • image
  45. DRUG METABOLISMS

  46. PHARMACOKINETICS

    1. You have full text access to this OnlineOpen article
      Population pharmacokinetics of exenatide

      Brenda Cirincione and Donald E. Mager

      Version of Record online: 16 NOV 2016 | DOI: 10.1111/bcp.13135

      • image
      • image
      • image
      • image
      • image
      • image
  47. CLINICAL TRIALS

    1. Biomarker-guided clinical development of the first-in-class anti-inflammatory FPR2/ALX agonist ACT-389949

      Anna K. Stalder, Dominik Lott, Daniel S. Strasser, Hans G. Cruz, Andreas Krause, Peter M.A. Groenen and Jasper Dingemanse

      Version of Record online: 15 NOV 2016 | DOI: 10.1111/bcp.13149

      • image
      • image
      • image
      • image
      • image
      • image
      • image
  48. PHARMACOEPIDEMIOLOGY

    1. You have full text access to this OnlineOpen article
      Spironolactone use and risk of incident cancers: a retrospective, matched cohort study

      Isla S. Mackenzie, Steven V. Morant, Li Wei, Alastair M. Thompson and Thomas M. MacDonald

      Version of Record online: 12 NOV 2016 | DOI: 10.1111/bcp.13152

      • image
      • image
      • image
  49. SYSTEMATIC REVIEWS

    1. Efficacy of bisphosphonate as an adjunct to nonsurgical periodontal therapy in the management of periodontal disease: a systematic review

      Zohaib Akram, Tariq Abduljabbar, Sergio Varela Kellesarian, Mohamed Ibrahim Abu Hassan, Fawad Javed and Fahim Vohra

      Version of Record online: 10 NOV 2016 | DOI: 10.1111/bcp.13147

      • image
      • image
      • image
      • image
  50. EDUCATION

    1. A multifaceted intervention to reduce drug-related complications in surgical patients

      Jacqueline M. Bos, Patricia M. L. A. van den Bemt, Wietske Kievit, Johan L. W. Pot, J. Elsbeth Nagtegaal, André Wieringa, Monique M. L. van der Westerlaken, Gert Jan van der Wilt, Peter A. G. M. de Smet and Cornelis Kramers

      Version of Record online: 10 NOV 2016 | DOI: 10.1111/bcp.13141

  51. LETTER TO THE EDITOR

    1. You have full text access to this OnlineOpen article
      The effect of inflammation on voriconazole trough concentrations in children

      Mendy ter Avest, Anette Veringa, Edwin R. van den Heuvel, Jos G. W. Kosterink, Elisabeth H. Schölvinck, Wim J. E. Tissing and Jan-Willem C. Alffenaar

      Version of Record online: 9 NOV 2016 | DOI: 10.1111/bcp.13151

      • image
  52. PAEDIATRIC CLINICAL PHARMACOLOGY

    1. Population pharmacokinetics and dosing recommendations for the use of deferiprone in children younger than 6 years

      Francesco Bellanti, Giovanni C. Del Vecchio, Maria C. Putti, Aurelio Maggio, Aldo Filosa, Carlo Cosmi, Laura Mangiarini, Michael Spino, John Connelly, Adriana Ceci, Oscar Della Pasqua and on behalf of the Consortium DEferiprone Evaluation in Paediatrics (DEEP)

      Version of Record online: 6 NOV 2016 | DOI: 10.1111/bcp.13134

      • image
      • image
      • image
      • image
  53. METHODS IN CLINICAL PHARMACOLOGY

    1. An original pharmacoepidemiological–pharmacodynamic method: application to antipsychotic-induced movement disorders

      Thi Thu Ha Nguyen, Antoine Pariente, Jean-Louis Montastruc, Maryse Lapeyre-Mestre, Vanessa Rousseau, Olivier Rascol, Bernard Bégaud and François Montastruc

      Version of Record online: 6 NOV 2016 | DOI: 10.1111/bcp.13145

      • image
      • image
      • image
  54. PHARMACOKINETICS

    1. Population pharmacokinetics of paritaprevir, ombitasvir, dasabuvir, ritonavir and ribavirin in hepatitis C virus genotype 1 infection: analysis of six phase III trials

      Sven Mensing, Doerthe Eckert, Shringi Sharma, Akshanth R. Polepally, Amit Khatri, Thomas J. Podsadecki, Walid M. Awni, Rajeev M. Menon and Sandeep Dutta

      Version of Record online: 3 NOV 2016 | DOI: 10.1111/bcp.13138

      • image
      • image
    2. You have full text access to this OnlineOpen article
      Population pharmacokinetics of daptomycin in adult patients undergoing continuous renal replacement therapy

      Xiaoying Xu, Dmytro Khadzhynov, Harm Peters, Ricardo L. Chaves, Kamal Hamed, Micha Levi and Natascia Corti

      Version of Record online: 28 OCT 2016 | DOI: 10.1111/bcp.13131

      • image
      • image
      • image
      • image
  55. DRUG SAFETY

    1. Utility of serum anti-cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab

      Benoît Dupont, Delphine Mariotte, Audrey E. Dugué, Bénédicte Clarisse, Jean-Michel Grellard, Emmanuel Babin, Bruno Chauffert, Stéphanie Dakpé, Cristian Moldovan, Karine Bouhier-Leporrier, Jean-Marie Reimund, Frederic Di Fiore, Sylvie Zanetta, Audrey Mailliez, Pascal Do, Annie Peytier, Marie-Pierre Galais, Carmen Florescu, Roland Schott, Brigitte Le Mauff and Radj Gervais

      Version of Record online: 24 OCT 2016 | DOI: 10.1111/bcp.13140

      • image
      • image
  56. PHARMACOEPIDEMIOLOGY

    1. You have full text access to this OnlineOpen article
      Patterns of antiplatelet drug use after a first myocardial infarction during a 10-year period

      Alfi Yasmina, Anthonius de Boer, Vera H.M. Deneer, Patrick C. Souverein and Olaf H. Klungel

      Version of Record online: 24 OCT 2016 | DOI: 10.1111/bcp.13139

      • image
      • image
      • image
  57. HUMAN TOXICOLOGY

    1. The effect of renal dysfunction and haemodialysis on circulating liver specific miR-122

      Laura Rivoli, A. D. Bastiaan Vliegenthart, Carmelita M. J. de Potter, Job J. M. H. van Bragt, Nikolaos Tzoumas, Peter Gallacher, Tariq E. Farrah, Neeraj Dhaun and James W. Dear

      Version of Record online: 21 OCT 2016 | DOI: 10.1111/bcp.13136

      • image
      • image
      • image
      • image
      • image
      • image
  58. PHARMACOGENETICS

    1. Polymorphisms in ABCB1 and CYP19A1 genes affect anastrozole plasma concentrations and clinical outcomes in postmenopausal breast cancer patients

      Guillermo Gervasini, Carlos Jara, Clara Olier, Nuria Romero, Ruth Martínez and Juan Antonio Carrillo

      Version of Record online: 18 OCT 2016 | DOI: 10.1111/bcp.13130

      • image
      • image
  59. DRUG INTERACTIONS

    1. Pharmacokinetics of neratinib during coadministration with lansoprazole in healthy subjects

      Kiana Keyvanjah, Daniel DiPrimeo, Ai Li, Mohammad Obaidi, Dennis Swearingen and Alvin Wong

      Version of Record online: 16 OCT 2016 | DOI: 10.1111/bcp.13132

      • image
      • image
  60. REVIEW-THEMED ISSUE

    1. Prevention of cardiotoxicity among survivors of childhood cancer

      Kelley K. Hutchins, Hani Siddeek, Vivian I. Franco and Steven E. Lipshultz

      Version of Record online: 12 OCT 2016 | DOI: 10.1111/bcp.13120

      • image
      • image
      • image
      • image

VIEW

  1. 1 - 66

SEARCH

SEARCH BY CITATION